» Articles » PMID: 35847556

Irradiation Combined with PD-L1 and Autophagy Inhibition Enhances the Antitumor Effect of Lung Cancer Via CGAS-STING-mediated T cell Activation

Overview
Journal iScience
Publisher Cell Press
Date 2022 Jul 18
PMID 35847556
Authors
Affiliations
Soon will be listed here.
Abstract

Radiotherapy combined with immune checkpoint blockade has gradually revealed the superiority in the antitumor therapy; however, the contribution of host PD-L1 remains elusive. In this study, we found that the activation of CD8 T cells was strikingly increased in both irradiated PD-L1-expressing primary tumor and distant non-irradiated syngeneic tumor in PD-L1-deficient mouse host, and thus enhanced radiation-induced antitumor abscopal effect (ATAE) by activating cGAS-STING pathway. Notably, the autophagy inhibitors distinctively promoted dsDNA aggregation in the cytoplasm and increased the release of cGAS-STING-regulated IFN-β from irradiated cells, which further activated bystander CD8 T cells to release IFN-γ and contributed to ATAE. These findings revealed a signaling cascade loop that the cytokines released from irradiated tumor recruit CD8 T cells that in turn act on the tumor cells with amplified immune responses in PD-L1-deficient host, indicating a potential sandwich therapy strategy of RT combined with PD-L1 blockage and autophagy inhibition.

Citing Articles

PARP inhibitor radiosensitization enhances anti-PD-L1 immunotherapy through stabilizing chemokine mRNA in small cell lung cancer.

Ran X, Wu B, Vidhyasagar V, Song L, Zhang X, Ladak R Nat Commun. 2025; 16(1):2166.

PMID: 40038278 PMC: 11880360. DOI: 10.1038/s41467-025-57257-z.


LAMTOR1 ablation impedes cGAS degradation caused by chemotherapy and promotes antitumor immunity.

Bie J, Li Y, Song C, Weng Q, Zhao L, Su L Proc Natl Acad Sci U S A. 2024; 121(41):e2320591121.

PMID: 39361643 PMC: 11474068. DOI: 10.1073/pnas.2320591121.


Endolysosomal transient receptor potential mucolipins and two-pore channels: implications for cancer immunity.

Ouologuem L, Bartel K Front Immunol. 2024; 15:1389194.

PMID: 38840905 PMC: 11150529. DOI: 10.3389/fimmu.2024.1389194.


The interplay between autophagy and cGAS-STING signaling and its implications for cancer.

Schmid M, Fischer P, Engl M, Widder J, Kerschbaum-Gruber S, Slade D Front Immunol. 2024; 15:1356369.

PMID: 38660307 PMC: 11039819. DOI: 10.3389/fimmu.2024.1356369.


cGAS suppresses hepatocellular carcinoma independent of its cGAMP synthase activity.

Ma D, Yang M, Sun C, Cui X, Xiong G, Wang Q Cell Death Differ. 2024; 31(6):722-737.

PMID: 38594443 PMC: 11164996. DOI: 10.1038/s41418-024-01291-9.


References
1.
Brahmer J, Tykodi S, Chow L, Hwu W, Topalian S, Hwu P . Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med. 2012; 366(26):2455-65. PMC: 3563263. DOI: 10.1056/NEJMoa1200694. View

2.
Freeman G, Long A, Iwai Y, Bourque K, Chernova T, Nishimura H . Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med. 2000; 192(7):1027-34. PMC: 2193311. DOI: 10.1084/jem.192.7.1027. View

3.
Parkes E, Walker S, Taggart L, McCabe N, Knight L, Wilkinson R . Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer. J Natl Cancer Inst. 2016; 109(1). PMC: 5441301. DOI: 10.1093/jnci/djw199. View

4.
Ricklefs F, Alayo Q, Krenzlin H, Mahmoud A, Speranza M, Nakashima H . Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles. Sci Adv. 2018; 4(3):eaar2766. PMC: 5842038. DOI: 10.1126/sciadv.aar2766. View

5.
Liauw S, Connell P, Weichselbaum R . New paradigms and future challenges in radiation oncology: an update of biological targets and technology. Sci Transl Med. 2013; 5(173):173sr2. PMC: 3769139. DOI: 10.1126/scitranslmed.3005148. View